178 related articles for article (PubMed ID: 11465593)
1. Role of heparin and nitric oxide in the cardiac and regional hemodynamic properties of protamine in conscious chronically instrumented dogs.
Oguchi T; Doursout MF; Kashimoto S; Liang YY; Hartley CJ; Chelly JE
Anesthesiology; 2001 Jun; 94(6):1016-25. PubMed ID: 11465593
[TBL] [Abstract][Full Text] [Related]
2. Cardiac and regional hemodynamic interactions between halothane and nitric oxide synthase activity in dogs.
Chelly JE; Doursout MF; Lechevalier T; Liang YY; Chelly F; Hartley C; Kilbourn RG
Anesthesiology; 1996 Jul; 85(1):142-9. PubMed ID: 8694360
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide inhibition attenuates systemic hypotension produced by protamine.
Raikar GV; Hisamochi K; Raikar BL; Schaff HV
J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1240-6; discussion 1246-7. PubMed ID: 8642826
[TBL] [Abstract][Full Text] [Related]
4. Role of propofol and its solvent, intralipid, in nitric oxide-induced peripheral vasodilatation in dogs.
Doursout MF; Joseph PM; Liang YY; Hartley CJ; Chelly JE
Br J Anaesth; 2002 Sep; 89(3):492-8. PubMed ID: 12402731
[TBL] [Abstract][Full Text] [Related]
5. Effects of a thromboxane receptor antagonist (NT-126) and a thromboxane synthase inhibitor (OKY-O46) on protamine-induced circulatory changes in dogs.
Mizutani T; Takahashi S; Kihara S; Toyooka H
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):687-92. PubMed ID: 11139110
[TBL] [Abstract][Full Text] [Related]
6. Repeated administration of protamine does not attenuate circulatory changes caused by protamine reversal of heparin in dogs.
Mizutani T; Takahashi S; Kihara S; Toyooka H
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):346-51. PubMed ID: 11426367
[TBL] [Abstract][Full Text] [Related]
7. Heparinase I (neutralase) reversal of systemic anticoagulation.
Michelsen LG; Kikura M; Levy JH; Lee MK; Lee KC; Zimmermann JJ; Szlam F
Anesthesiology; 1996 Aug; 85(2):339-46. PubMed ID: 8712450
[TBL] [Abstract][Full Text] [Related]
8. Protamine sulfate causes endothelium-independent vasorelaxation via inducible nitric oxide synthase pathway.
Takakura K; Mizogami M; Fukuda S
Can J Anaesth; 2006 Feb; 53(2):162-7. PubMed ID: 16434757
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of NG-methyl-L-arginine in chronically instrumented conscious dogs.
Lechevalier T; Doursout MF; Chelly JE; Kilbourn RG
J Appl Physiol (1985); 1994 Jul; 77(1):471-5. PubMed ID: 7525530
[TBL] [Abstract][Full Text] [Related]
10. Systemic hypotensive response to protamine following chronic inhibition of nitric oxide synthase in rats.
Komatsu H; Enzan K; Matsuura S; Kurosawa S; Mitsuhata H
Can J Anaesth; 1998 Dec; 45(12):1186-9. PubMed ID: 10051937
[TBL] [Abstract][Full Text] [Related]
11. The systemic vasodilatory action of protamine: is it inhibited or mediated by heparin?
Ordoñez Fernandez A; Hernandez Fernandez A; Borrego Dominguez JM; Garcia Tejero P; Perez Bernal J; Hinojosa R; Lopez Hidalgo J
Res Exp Med (Berl); 1998 Apr; 197(6):337-47. PubMed ID: 9638796
[TBL] [Abstract][Full Text] [Related]
12. Protamine induces endothelium-dependent vasodilatation of the pulmonary artery.
Evora PR; Pearson PJ; Schaff HV
Ann Thorac Surg; 1995 Aug; 60(2):405-10. PubMed ID: 7646104
[TBL] [Abstract][Full Text] [Related]
13. Protamine after heparin produces hypotension resulting from decreased sympathetic outflow secondary to increased nitric oxide in the central nervous system.
Hamada Y; Kameyama Y; Narita H; Benson KT; Goto H
Anesth Analg; 2005 Jan; 100(1):33-37. PubMed ID: 15616048
[TBL] [Abstract][Full Text] [Related]
14. Decreased oxygen consumption as a toxic manifestation of protamine sulfate reversal of heparin anticoagulation.
Wakefield TW; Ucros I; Kresowik TF; Hinshaw DB; Stanley JC
J Vasc Surg; 1989 Jun; 9(6):772-7. PubMed ID: 2724464
[TBL] [Abstract][Full Text] [Related]
15. Effects of N-methyl-L-arginine on cardiac and regional blood flow in a dog endotoxin shock model.
Doursout MF; Kilbourn RG; Hartley CJ; Chelly JE
J Crit Care; 2000 Mar; 15(1):22-9. PubMed ID: 10757195
[TBL] [Abstract][Full Text] [Related]
16. Protamine releases endothelium-derived relaxing factor from systemic arteries. A possible mechanism of hypotension during heparin neutralization.
Pearson PJ; Evora PR; Ayrancioglu K; Schaff HV
Circulation; 1992 Jul; 86(1):289-94. PubMed ID: 1617779
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cardiac and regional hemodynamic responses to N-methyl-L-arginine and aminoguanidine infusions in conscious pigs.
Doursout MF; Hartley CJ; Chelly JE
J Cardiovasc Pharmacol; 2001 Apr; 37(4):349-58. PubMed ID: 11300647
[TBL] [Abstract][Full Text] [Related]
18. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
Stefaniszyn HJ; Novick RJ; Salerno TA
J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
[TBL] [Abstract][Full Text] [Related]
20. [Hemodynamic effects of sub-chronic NO synthase inhibition in conscious dogs: role of EDRF/NO in muscular exertion].
Puybasset L; Béa ML; Simon L; Ghaleh B; Giudicelli JF; Berdeaux A
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1217-21. PubMed ID: 8572877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
